Ticagrelor | |
In the evolving world of cardiovascular medicine, Ticagrelor has emerged as a revolutionary antiplatelet medication. Its ability to reduce the risk of thrombotic cardiovascular events, particularly in patients with acute coronary syndromes (ACS), sets it apart as a critical drug in cardiology. At Valence Labs, we take pride in manufacturing high-qualityAPI and finished formulations that meet global standards, ensuring both safety and efficacy. Ticagrelor is an oral antiplatelet drug that belongs to a class of medications known as P2Y12 receptor antagonists. Unlike clopidogrel and prasugrel, Its is reversible and does not require hepatic activation, offering a faster onset and more predictable platelet inhibition. It’s primarily used in combination with aspirin to prevent serious cardiovascular events such as heart attack or stroke in patients with ACS. Chemical Properties of Ticagrelor: Molecular Formula: C23H28F2N6O4S Molecular Weight: 522.57 g/mol Mechanism of Action: Inhibits ADP-induced platelet aggregation via the P2Y12 receptor. Bioavailability: 36% | |
Related Link: Click here to visit item owner's website (0 hit) | |
Target State: All States Target City : Punjab Last Update : 02 July 2025 5:15 PM Number of Views: 16 | Item Owner : Valence Labs Contact Email: Contact Phone: +91-98156 66305 |
Friendly reminder: Click here to read some tips. |